Regular Article
Respiratory Allergenicity of Detergent Enzymes in the Guinea Pig Intratracheal Test: Association with Sensitization of Occupationally Exposed Individuals

https://doi.org/10.1006/faat.1997.2356Get rights and content

Abstract

A guinea pig intratracheal test was used to set occupational operating guidelines for new enzyme proteins used in the detergent industry. In these studies, animals were intratracheally dosed with different levels of enzyme protein and sera from the animals were titered for allergic antibody to the enzyme. The amount of antibody produced to an enzyme was compared to the amount of antibody produced to the same protein doses of Alcalase, for which effective operating guidelines exist. These comparisons were used to determine if a new enzyme was more potent, less potent, or equivalent to Alcalase; operating guidelines were then established for the new enzyme. Termamyl was about 10-fold more potent than Alcalase and the protease subtilisin B was shown to be less potent. Another protease, Savinase, was shown to be equivalent in potency to Alcalase. The operating guidelines for Termamyl were adjusted lower, whereas the operating guidelines for the proteases were set the same as that of Alcalase. Under these conditions, we would predict that sensitizations to new enzymes would be comparable to or lower than the sensitizations to Alcalase. Prospective evaluation of skin prick test data of factory workers showed that sensitizations to Termamyl and Savinase were similar to sensitizations to Alcalase. The sensitizations to subtilisin B were lower than those to Alcalase. During this time period (7 years), only three respiratory incidents (rhinitis) were reported, demonstrating that employees with positive skin prick tests can continue to work. These comparisons indicate that the guinea pig intratracheal test is a good animal model for evaluating enzymes as respiratory allergens and that the data generated can be used to set operating guidelines for occupational allergens.

References (22)

There are more references available in the full text version of this article.

Cited by (48)

  • Impact strength distribution of placebo enzyme granules

    2015, Powder Technology
    Citation Excerpt :

    The current enzyme granule manufacturing produces strong granules; however, a very small number of them are weak, and prone to breakage. The protein dust (particles smaller than 100 μm) can potentially cause respiratory allergy and asthma, as investigated in the late 1960's by Pepys et al. [2] and Flindt [3], and the effects of the enzyme dust on the workers in a detergent manufacturing plant have been reported by Sarlo et al. [4] and Vanhanen et al. [5]. Hence, it is very important for manufacturing to examine the dustiness and strength of the enzyme granules.

  • Contact Urticaria Syndrome: Clinical Aspects

    2014, Applied Dermatotoxicology: Clinical Aspects
  • Enzymes in cleaning products: An overview of toxicological properties and risk assessment/management

    2012, Regulatory Toxicology and Pharmacology
    Citation Excerpt :

    In contradistinction to the situation with skin, exposure of the respiratory tract to enzyme proteins does have the potential to progress beyond a normal immune response and to give rise to the production of antigen specific IgE. Although there is published evidence that enzymes can drive the formation of anaphylactic IgE antibodies in animal models (Sarlo et al., 1997; Robinson et al., 1998; Basketter et al., 2012a), the most critical information derives from human experience. It is well known that sufficient exposure can lead to the clinical symptoms of allergy including asthma.

  • Chapter 7 Nonclinical evaluation of the potential for hypersensitivity

    2004, Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach
  • Control of occupational asthma and allergy in the detergent industry

    2003, Annals of Allergy, Asthma and Immunology
View all citing articles on Scopus

This work was funded by the Procter & Gamble Co. (Cincinnati, OH).

2

Current address: Scott and White Clinic, 1600 University Drive East, College Station, TX 77845.

View full text